These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23643867)

  • 1. Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers.
    Xiang SD; Wilson K; Day S; Fuchsberger M; Plebanski M
    Methods; 2013 May; 60(3):232-41. PubMed ID: 23643867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The signalling imprints of nanoparticle uptake by bone marrow derived dendritic cells.
    Karlson Tde L; Kong YY; Hardy CL; Xiang SD; Plebanski M
    Methods; 2013 May; 60(3):275-83. PubMed ID: 23459257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles modify dendritic cell homeostasis and induce non-specific effects on immunity to malaria.
    Xiang SD; Kong YY; Hanley J; Fuchsberger M; Crimeen-Irwin B; Plebanski M
    Trans R Soc Trop Med Hyg; 2015 Jan; 109(1):70-6. PubMed ID: 25573111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of local immune responses induced by a novel nano-particle based carrier-adjuvant in sheep.
    Gamvrellis A; Gloster S; Jefferies M; Mottram PL; Smooker P; Plebanski M; Scheerlinck JP
    Vet Immunol Immunopathol; 2013 Sep; 155(1-2):21-9. PubMed ID: 23806674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo.
    Powell TJ; Palath N; DeRome ME; Tang J; Jacobs A; Boyd JG
    Vaccine; 2011 Jan; 29(3):558-69. PubMed ID: 20951665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles target distinct dendritic cell populations according to their size.
    Manolova V; Flace A; Bauer M; Schwarz K; Saudan P; Bachmann MF
    Eur J Immunol; 2008 May; 38(5):1404-13. PubMed ID: 18389478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8
    Xiang SD; Wilson KL; Goubier A; Heyerick A; Plebanski M
    Front Immunol; 2018; 9():2968. PubMed ID: 30631324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
    Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
    Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis.
    Ballester M; Nembrini C; Dhar N; de Titta A; de Piano C; Pasquier M; Simeoni E; van der Vlies AJ; McKinney JD; Hubbell JA; Swartz MA
    Vaccine; 2011 Sep; 29(40):6959-66. PubMed ID: 21787826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
    Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
    Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts.
    Malowany JI; McCormick S; Santosuosso M; Zhang X; Aoki N; Ngai P; Wang J; Leitch J; Bramson J; Wan Y; Xing Z
    Mol Ther; 2006 Apr; 13(4):766-75. PubMed ID: 16343993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8
    Darling R; Senapati S; Christiansen J; Liu L; Ramer-Tait AE; Narasimhan B; Wannemuehler M
    Int J Nanomedicine; 2020; 15():6579-6592. PubMed ID: 32982219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to vaccines involving a combined antigen-nanoparticle mixture and nanoparticle-encapsulated antigen formulation.
    Zhang W; Wang L; Liu Y; Chen X; Liu Q; Jia J; Yang T; Qiu S; Ma G
    Biomaterials; 2014 Jul; 35(23):6086-97. PubMed ID: 24780166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic analysis of ovine antigen presenting cells loaded with nanoparticles migrating from the site of vaccination.
    Gamvrellis A; Walsh K; Tatarczuch L; Smooker P; Plebanski M; Scheerlinck JP
    Methods; 2013 May; 60(3):257-63. PubMed ID: 23454300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential uptake of nanoparticles and microparticles by pulmonary APC subsets induces discrete immunological imprints.
    Hardy CL; Lemasurier JS; Mohamud R; Yao J; Xiang SD; Rolland JM; O'Hehir RE; Plebanski M
    J Immunol; 2013 Nov; 191(10):5278-90. PubMed ID: 24123688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyelectrolyte Multilayers Assembled Entirely from Immune Signals on Gold Nanoparticle Templates Promote Antigen-Specific T Cell Response.
    Zhang P; Chiu YC; Tostanoski LH; Jewell CM
    ACS Nano; 2015 Jun; 9(6):6465-77. PubMed ID: 26035231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo targeting of human DC-SIGN drastically enhances CD8⁺ T-cell-mediated protective immunity.
    Hesse C; Ginter W; Förg T; Mayer CT; Baru AM; Arnold-Schrauf C; Unger WW; Kalay H; van Kooyk Y; Berod L; Sparwasser T
    Eur J Immunol; 2013 Oct; 43(10):2543-53. PubMed ID: 23784881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U; Meissner A; Scheidig C; Körner H
    Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells.
    Cruz LJ; Tacken PJ; Fokkink R; Figdor CG
    Biomaterials; 2011 Oct; 32(28):6791-803. PubMed ID: 21724247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.